FRIDAY, May 19, 2023 (HealthDay News) — Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib). Rinvoq is meant to treat adults with moderately to severely active Crohn’s disease who have not had success with TNF (tumorContinue Reading

THURSDAY, May 18, 2023 (HealthDay News) — The first vaccine designed to protect infants against respiratory syncytial virus (RSV) by vaccinating their mothers during pregnancy has been backed by a panel of advisers to the U.S. Food and Drug Administration. On Thursday the independent committee of experts voted unanimously thatContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — Medications that treat opioid addiction and prevent overdose deaths are drastically under-prescribed in the United States, particularly for Black patients, a new study has found. Disabled people on Medicare are not likely to be prescribed either buprenorphine – the best medication for treatingContinue Reading